USFDA grants orphan drug designation to Sanofi Rilzabrutinib for two rare diseases Ruchika Sharma3 April 2025 2:45 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to Rilzabrutinib, an...
FDA Approves fitusiran for Hemophilia A and B Dr. Kamal Kant Kohli2 April 2025 9:15 AM ISTThe FDA has approved fitusiran, now named Qfitlia, for routine prophylaxis in patients aged 12 and older with hemophilia A or B, with or without...
Sanofi Dupixent approved in Japan for COPD Ruchika Sharma30 March 2025 10:00 AM ISTDupixent is intended for injection under the skin (subcutaneous injection) and is given every other week.
USFDA approves Sanofi Qfitlia for hemophilia A or B with or without inhibitors Ruchika Sharma29 March 2025 11:30 AM ISTParis: Sanofi has announced that the Company has received approval from the US Food and Drug Administration (FDA) for Qfitlia...
Sanofi gets USFDA fast track designation for Chlamydia vaccine candidate Ruchika Sharma27 March 2025 3:22 PM ISTParis: Sanofi has received the US Food and Drug Administration (USFDA) fast-track designation for its mRNA vaccine candidate for the...
Sanofi Tolebrutinib under USFDA priority review for multiple sclerosis Ruchika Sharma25 March 2025 12:15 PM ISTTolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory authority.
Sanofi to buy Autoimmune Disease treatment from Dren Bio for up to USD 1.9 billion Ruchika Sharma20 March 2025 11:30 AM ISTParis: Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi...
Sanofi Sarclisa combo gets Japanese nod for newly diagnosed multiple myeloma Ruchika Sharma27 Feb 2025 11:30 AM ISTParis: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with...
Former FDA director Patrizia Cavazzoni rejoins Pfizer Ruchika Sharma25 Feb 2025 1:30 PM ISTNew York: Pfizer Inc. has announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer, Executive Vice President.In...
Sanofi nears selling 50 percent controlling stake in Opella to CD&R Ruchika Sharma21 Feb 2025 6:16 PM ISTParis: Sanofi and CD&R have announced that they have signed the share purchase agreement in relation to the sale of a 50 percent controlling...
USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoid Ruchika Sharma20 Feb 2025 12:30 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license...
Sanofi's Merilog Receives USFDA Approval as Biosimilar to Novolog for Diabetes Management Farhat Nasim17 Feb 2025 7:56 PM ISTNew Delhi: Sanofi has received U.S. Food and Drug Administration (FDA) approval for Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin...
